Guenter Janhofer

Insider Reports History

Entity
Individual
Location
601 Gateway Boulevard, Suite 1250, South San Francisco, CA
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Guenter Janhofer, M.D., Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Guenter Janhofer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Chief Scientific Officer Common Stock 15K $14.1K $0.94 Oct 23, 2023 Direct
Quince Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 300K Oct 23, 2023 Direct

Insider Reports Filed by Guenter Janhofer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Quince Therapeutics, Inc. Oct 23, 2023 1 $0 4 Oct 24, 2023 Chief Scientific Officer
QNCX Quince Therapeutics, Inc. Oct 23, 2023 0 $0 3 Oct 24, 2023 Chief Scientific Officer